Corteva (NYSE:CTVA) Releases Earnings Results, Beats Estimates By $0.32 EPS

Key Points

• Earnings beat and guidance raise: Corteva reported Q1 EPS of $1.50 versus $1.18 expected and revenue of $4.91B, and updated FY2026 EPS guidance to 3.45–3.70.
• Revenue growth and market reaction: Revenue was up 11% year‑over‑year and shares jumped about 2.7% to $83.91, with a market cap near $56.3B and a P/E of 53.1.
• Dividend and insider activity: The company declared a quarterly dividend of $0.18 (annualized $0.72, yield 0.9%; ex‑dividend June 1), while insider Brian Titus sold 8,311 shares and corporate insiders hold about 0.15% of stock.

Corteva (NYSE:CTVA - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported $1.50 EPS for the quarter, topping analysts' consensus estimates of $1.18 by $0.32, Zacks reports. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva's revenue was up 11.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $1.13 earnings per share. Corteva updated its FY 2026 guidance to 3.450-3.700 EPS.

Corteva Stock Up 2.7%

Shares of NYSE CTVA traded up $2.22 during trading on Tuesday, hitting $83.91. 5,008,023 shares of the company traded hands, compared to its average volume of 3,983,275. The business's fifty day moving average is $80.39 and its 200 day moving average is $72.18. Corteva has a fifty-two week low of $60.53 and a fifty-two week high of $85.63. The firm has a market capitalization of $56.33 billion, a price-to-earnings ratio of 53.11, a P/E/G ratio of 2.77 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.43.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a dividend of $0.18 per share. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva's dividend payout ratio is currently 45.57%.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of the company's stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.15% of the company's stock.

Hedge Funds Weigh In On Corteva

Several institutional investors have recently made changes to their positions in the stock. Kelleher Financial Advisors raised its holdings in shares of Corteva by 3.8% during the third quarter. Kelleher Financial Advisors now owns 4,594 shares of the company's stock valued at $311,000 after purchasing an additional 170 shares during the period. Binnacle Investments Inc increased its stake in Corteva by 54.7% during the 2nd quarter. Binnacle Investments Inc now owns 512 shares of the company's stock valued at $38,000 after purchasing an additional 181 shares in the last quarter. Cresset Asset Management LLC raised its holdings in Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company's stock worth $526,000 after buying an additional 181 shares during the last quarter. CreativeOne Wealth LLC raised its holdings in Corteva by 2.6% during the fourth quarter. CreativeOne Wealth LLC now owns 7,699 shares of the company's stock worth $516,000 after buying an additional 194 shares during the last quarter. Finally, Quadrant Capital Group LLC raised its holdings in Corteva by 1.4% during the fourth quarter. Quadrant Capital Group LLC now owns 14,500 shares of the company's stock worth $972,000 after buying an additional 198 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company's stock.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Weiss Ratings restated a "hold (c)" rating on shares of Corteva in a report on Wednesday, April 22nd. Zacks Research lowered shares of Corteva from a "strong-buy" rating to a "hold" rating in a report on Friday, February 20th. Wells Fargo & Company boosted their target price on shares of Corteva from $85.00 to $90.00 and gave the company an "overweight" rating in a report on Tuesday, April 21st. Bank of America boosted their target price on shares of Corteva from $80.00 to $82.00 and gave the company a "buy" rating in a report on Thursday, January 8th. Finally, Citigroup boosted their target price on shares of Corteva from $74.00 to $80.00 and gave the company a "neutral" rating in a report on Thursday, February 5th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $86.38.

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.